Exclusive Summary

• Capitalize on patent cliffs or high technical barriers to secure First-to-Market or early-entry opportunities globally.
• Target high-burden therapeutic areas aligned with first-line international guidelines, ensuring rigid and sustainable demand.
• Leverage China’s vertically integrated supply chain to offer superior cost-efficiency compared to originators and global competitors.
• The NewCo model facilitates deep localization, accelerating regulatory access and maximizing commercial value through shared risk/reward.

Asset Materials

Contact Us for Full Materials